Trinity Biotech

NASDAQ: TRIB · Real-Time Price · USD
1.63
-0.28 (-14.66%)
At close: Aug 15, 2025, 3:59 PM
1.50
-7.98%
After-hours: Aug 15, 2025, 05:11 PM EDT

Trinity Biotech Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.17M 3.69M 6.58M 25.91M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
2.46M 214K 212K 151K
Other Long-Term Assets
194K 43K 55K 56K
Receivables
14.6M 13.38M 13.45M 15.71M
Inventory
19.37M 19.93M 22.5M 29.12M
Other Current Assets
n/a n/a 2.21M n/a
Total Current Assets
41.12M 39.04M 46.67M 72.69M
Property-Plant & Equipment
4.62M 1.89M 5.68M 5.92M
Goodwill & Intangibles
51.34M 16.27M 35.27M 35.98M
Total Long-Term Assets
62.17M 20.39M 45.44M 46.21M
Total Assets
103.29M 59.44M 92.1M 118.89M
Account Payables
6.83M 3.88M 6.21M 6.76M
Deferred Revenue
197K 50K 114K 141K
Short-Term Debt
210K 210K 210K 83.31M
Other Current Liabilities
2.57M 160K 153K 249K
Total Current Liabilities
32.09M 15.04M 17.34M 100.49M
Long-Term Debt
87.79M 54.65M 58.05M n/a
Other Long-Term Liabilities
3.55M 526K 1.57M n/a
Total Long-Term Liabilities
106.38M 68.35M 76.94M 18.72M
Total Liabilities
138.47M 83.38M 94.28M 119.21M
Total Debt
100.76M 67.43M 58.26M 99.16M
Common Stock
4.19M 1.97M 1.96M 1.21M
Retained Earnings
-79.12M -48.64M -26.7M 12.56M
Comprehensive Income
-5.44M 1.03M -5.69M -5.36M
Shareholders Equity
-35.18M -23.95M -2.18M -319K
Total Investments
2.46M 214K 212K 151K